We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chemours Upsizes and Prices $700 Million Senior Notes Offering
Read MoreHide Full Article
Key Takeaways
Chemours priced $700M of 7.875% senior notes due March 15, 2034, upsized from $600M.
Proceeds will redeem 5.375% notes due 2027 and partly redeem 5.750% notes due 2028.
The senior unsecured notes are guaranteed by subsidiaries and close on March 12, 2026.
The Chemours Company (CC - Free Report) has recently priced a private offering of $700 million aggregate principal amount of 7.875% senior notes due 2034. This increases the offering size from the initially announced $600 million.
With maturity scheduled on March 15, 2034, the interest payments on the notes will be made on a semi-annual basis. This senior unsecured obligation of Chemours will be guaranteed by certain of its subsidiaries, with expected closure of the offering on March 12, 2026, subject to customary closing conditions.
Chemours plans to use the net proceeds to redeem its outstanding 5.375% senior notes due 2027 and partially redeem its 5.750% senior notes due 2028. This will enhance the company’s debt profile.
The notes and related guarantees were offered to qualified institutional buyers under Rule 144A of the Securities Act of 1933, as amended, and to non-U.S. persons outside the United States in accordance with Regulation S. The securities may not be offered in the United States without registration or an applicable exemption.
CC stock has gained 31.6% over the past year compared with the industry’s 9.8% decline.
Image Source: Zacks Investment Research
CC’s Zacks Rank & Key Picks
CC currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , Compañía de Minas Buenaventura S.A.A. (BVN - Free Report) and Balchem Corporation (BCPC - Free Report) .
The Zacks Consensus Estimate for ALB’s 2026 earnings is pegged at $6.41 per share, indicating a rise of 911.4% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 57.8%. ALB’s shares have soared 155.4% over the past year.
The Zacks Consensus Estimate for BVN’s 2026 earnings is pinned at $2.16 per share, indicating a 35.85% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, with an average surprise of 28.02%. Its shares have jumped 241.2% over the past year.
The Zacks Consensus Estimate for BCPC’s 2026 earnings is pinned at $5.53 per share, indicating a 7.4% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the four trailing quarters. BCPC’s shares have gained 5.1% over the past year.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Chemours Upsizes and Prices $700 Million Senior Notes Offering
Key Takeaways
The Chemours Company (CC - Free Report) has recently priced a private offering of $700 million aggregate principal amount of 7.875% senior notes due 2034. This increases the offering size from the initially announced $600 million.
With maturity scheduled on March 15, 2034, the interest payments on the notes will be made on a semi-annual basis. This senior unsecured obligation of Chemours will be guaranteed by certain of its subsidiaries, with expected closure of the offering on March 12, 2026, subject to customary closing conditions.
Chemours plans to use the net proceeds to redeem its outstanding 5.375% senior notes due 2027 and partially redeem its 5.750% senior notes due 2028. This will enhance the company’s debt profile.
The notes and related guarantees were offered to qualified institutional buyers under Rule 144A of the Securities Act of 1933, as amended, and to non-U.S. persons outside the United States in accordance with Regulation S. The securities may not be offered in the United States without registration or an applicable exemption.
CC stock has gained 31.6% over the past year compared with the industry’s 9.8% decline.
Image Source: Zacks Investment Research
CC’s Zacks Rank & Key Picks
CC currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , Compañía de Minas Buenaventura S.A.A. (BVN - Free Report) and Balchem Corporation (BCPC - Free Report) .
While ALB and BVN sport a Zacks Rank #1 (Strong Buy) each at present, BCPC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ALB’s 2026 earnings is pegged at $6.41 per share, indicating a rise of 911.4% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 57.8%. ALB’s shares have soared 155.4% over the past year.
The Zacks Consensus Estimate for BVN’s 2026 earnings is pinned at $2.16 per share, indicating a 35.85% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, with an average surprise of 28.02%. Its shares have jumped 241.2% over the past year.
The Zacks Consensus Estimate for BCPC’s 2026 earnings is pinned at $5.53 per share, indicating a 7.4% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the four trailing quarters. BCPC’s shares have gained 5.1% over the past year.